Literature DB >> 10530609

Pregnancy recency and risk of ovarian cancer.

G S Cooper1, J M Schildkraut, A S Whittemore, P A Marchbanks.   

Abstract

OBJECTIVE: A recent analysis suggested that ovarian cancer risk increased with time since last birth, possibly because of some aspect of pregnancy that affects the clearance of cells that have undergone malignant transformation. We analyzed data from four case-control studies pertaining to ovarian cancer risk in relation to age at first pregnancy, age at last pregnancy, and years since last pregnancy: 628 cases and 3432 neighborhood or population controls, ages 18-79, were included.
METHODS: We used logistic regression to analyze associations between ovarian cancer risk, controlling for study, age (at diagnosis or corresponding reference age for controls), race, parity, oral contraceptive use, tubal ligation, family history of ovarian or breast cancer, and excluding women with a history of infertility.
RESULTS: An early age at first pregnancy was associated with an increased risk of ovarian cancer (odds ratio 1.4, 95% confidence interval (1.1-1.8) for ages < or =19 compared to > or =25). Years since last pregnancy was also associated with increased ovarian cancer risk, with odds ratios of 1.4, 1.4, 1.8, and 2.1 for 10-14, 15-19, 20-24, and > or =25 years compared to 0-9 years (trend test p = 0.004), respectively.
CONCLUSION: These observations support the results from the previous study, and raise additional questions about the role of pregnancy in the etiology of ovarian cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10530609     DOI: 10.1023/a:1008960520316

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  10 in total

1.  Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women.

Authors:  Joellen M Schildkraut; Lauren C Peres; Traci N Bethea; Fabian Camacho; Deanna Chyn; Emily K Cloyd; Elisa V Bandera; Alicia Beeghly-Fadiel; Loren Lipworth; Charlotte E Joslin; Faith G Davis; Patricia G Moorman; Evan Myers; Heather M Ochs-Balcom; Veronica Wendy Setiawan; Malcolm C Pike; Anna H Wu; Lynn Rosenberg
Journal:  Cancer Causes Control       Date:  2019-06-24       Impact factor: 2.506

2.  Reproductive factors and ovarian cancer risk in African-American women.

Authors:  Patricia G Moorman; Anthony J Alberg; Elisa V Bandera; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Edward S Peters; Ann G Schwartz; Paul Terry; Sydnee Crankshaw; Frances Wang; Joellen M Schildkraut
Journal:  Ann Epidemiol       Date:  2016-07-18       Impact factor: 3.797

3.  Primary peritoneal and ovarian cancers: an epidemiological comparative analysis.

Authors:  Delores J Grant; Patricia G Moorman; Lucy Akushevich; Rachel T Palmieri; Rex C Bentley; Joellen M Schildkraut
Journal:  Cancer Causes Control       Date:  2010-03-23       Impact factor: 2.506

Review 4.  Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin.

Authors:  Celeste Leigh Pearce; Karine Chung; Malcolm C Pike; Anna H Wu
Journal:  Cancer       Date:  2009-02-01       Impact factor: 6.860

5.  Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women.

Authors:  Patricia G Moorman; Brian Calingaert; Rachel T Palmieri; Edwin S Iversen; Rex C Bentley; Susan Halabi; Andrew Berchuck; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2008-02-25       Impact factor: 4.897

Review 6.  Protective Effect of Progesterone during Pregnancy against Ovarian Cancer.

Authors:  Kyung Hee Han; Mi-Kyung Kim; Hee Seung Kim; Hyun Hoon Chung; Yong Sang Song
Journal:  J Cancer Prev       Date:  2013-06

7.  Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.

Authors:  C L Pearce; A H Wu; S A Gayther; A E Bale; P A Beck; J Beesley; S Chanock; D W Cramer; R DiCioccio; R Edwards; Z S Fredericksen; M Garcia-Closas; E L Goode; A C Green; L C Hartmann; E Hogdall; S K Kjaer; J Lissowska; V McGuire; F Modugno; K Moysich; R B Ness; S J Ramus; H A Risch; T A Sellers; H Song; D O Stram; K L Terry; P M Webb; D C Whiteman; A S Whittemore; W Zheng; P D P Pharoah; G Chenevix-Trench; M C Pike; J Schildkraut; A Berchuck
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

8.  Histological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women Study.

Authors:  Kezia Gaitskell; Jane Green; Kirstin Pirie; Isobel Barnes; Carol Hermon; Gillian K Reeves; Valerie Beral
Journal:  Int J Cancer       Date:  2017-10-12       Impact factor: 7.396

9.  Age at first birth and long-term mortality for mothers: the Ohsaki cohort study.

Authors:  Taichi Sakai; Yumi Sugawara; Ikue Watanabe; Takashi Watanabe; Yasutake Tomata; Naoki Nakaya; Ichiro Tsuji
Journal:  Environ Health Prev Med       Date:  2017-04-04       Impact factor: 3.674

10.  Age at last birth and risk of developing epithelial ovarian cancer: a meta-analysis.

Authors:  Yanjun Wu; Wenjun Sun; Xueling Xin; Weijing Wang; Dongfeng Zhang
Journal:  Biosci Rep       Date:  2019-09-13       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.